Drugs / ATX-GD-59
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02973802 | Sep 2016 → Feb 2018 | Graves disease | Apitope International NV | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ATX-GD-59 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02973802 ↗ |
| Route | Other | “by intradermal injection” NCT02973802 ↗ |